Expression of Tumor Necrosis Factor-alpha-induced Protein 8 in Pancreas Tissues and its Correlation with Epithelial Growth Factor Receptor Levels |
Liu, Ke
(Department of Hepatobiliary, Provincial Hospital affiliated to Shandong University)
Qin, Cheng-Kun (Department of Hepatobiliary, Provincial Hospital affiliated to Shandong University) Wang, Zhi-Yi (Department of Hepatobiliary, Provincial Hospital affiliated to Shandong University) Liu, Su-Xia (Department of immunology, Shandong University School of Medicine) Cui, Xian-Ping (Department of Hepatobiliary, Provincial Hospital affiliated to Shandong University) Zhang, Dong-Yuan (Department of Hepatobiliary, Provincial Hospital affiliated to Shandong University) |
1 | Aggarwal S, Gupta S, Gupta MK, et al (2011). Possible role of epidermal growth factor receptors in the therapy of pancreatic cancer. Crit Rev Ther Drug Carrier Syst, 28, 293-356. DOI |
2 | Azizi A, Naguib NN, Mbalisike E, et al (2011). Liver metastases of pancreatic cancer: role of repetitive transarterial chemoembolization (TACE) on tumor response and survival. Pancreas, 40, 1271-5. DOI |
3 | Dong QZ, Zhao Y, Liu Y, et al (2010). Overexpression of SCC-S2 correlates with lymph node metastasis and poor prognosis in patients with non-small-cell lung. Cancer Sci, 101, 1562-9. DOI |
4 | Freundt EC, Bidere N, Lenardo MJ (2008). A different TIPE of immune homeostasis. Cell, 133, 401-2. DOI |
5 | Hong SM, Park JY, Hruban RH, et al (2011). Molecular signatures of pancreatic cancer. Arch Pathol Lab Med, 135, 716-27. |
6 | Ioannou N, Dalgleish AG, Seddon AM, et al (2011). Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells. Br J Cancer, 105, 1554-62. DOI |
7 | Kumar D, Whiteside TL, Kasid U (2000). Identification of a novel tumor necrosis factor-alpha-inducible gene, SCC-S2, containing the consensus sequence of a death effector domain of fas-associated death domain-like interleukin- 1beta-converting enzyme-inhibitory protein. J Biol Chem, 275, 2973-8. DOI |
8 | Kumar D, Gokhale P, Broustas C et al (2004). Expression of SCC-S2, a antiapoptotic molecule, correlates with enhanced proliferation antumorigenicity of MDA-MB 435 cells. Oncogene, 23, 612-6. DOI |
9 | Patel S, Wang FH, Whiteside TL, et al(1997). Identification of seven differentially displayed transcripts in human primary and matched metastatic head and neck squamous cell carcinoma cell lines: implications in metastasis and/or radiation response. Oral Oncol, 33, 197-203. DOI |
10 | Romanuik TL, Ueda T, Le N, et al (2009). Novel biomarkers for prostate cancer including noncoding transcripts. Am J Pathol, 175, 2264-76. DOI |
11 | Sharma C, Eltawil KM, Renfrew PD, et al (2011). Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. World J Gastroenterol, 17, 867-97. DOI |
12 | Sun H, Gong S, Carmody RJ, et al (2008). TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell, 133, 415-26. DOI |
13 | Vincent A, Herman J, Schulick R, et al (2011). Pancreatic cancer. Lancet, 378, 607-20. DOI ScienceOn |
14 | Xu S, Weihua Z (2011). Loss of EGFR induced autophagy sensitizes hormone refractory prostate cancer cells to adriamycin. Prostate, 71, 1216-24. DOI |
15 | You Z, Ouyang H, Lopatin D, et al (2001). Nuclear factorkappa B-inducible death effector domain-containing protein suppresses tumor necrosis factor-mediated apoptosis by inhibiting caspase-8 activity. J Biol Chem, 276, 26398-404. DOI |
16 | Zhang C, Chakravarty D, Sakabe I, et al (2006). Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. Mol Ther, 13, 947-55. DOI |
![]() |